Towards the development of improved, AI-based risk stratification tools for the secondary prevention of coronary heart disease (CHD) we work in close collaboration with John Deanfield (UK, Institute of Cardiovascular Science, University College London, UCL) and Ulf Landmesser (Cardiology, Charité).
In 2019, John Deanfield was appointed an Einstein BIH Visiting Fellow/Professor. His main objective is to foster bilateral research projects in cardiovascular prevention between UCL and Charité/BIH with the aim of applying AI in large existing national datasets. Thus, this Einstein award has brought together the Cardiovascular Programme at the Charité, Berlin and the Barts Heart Centre (UCL), London with our expertise at the BIH Center for Digital Health. Our close collaboration is manifested in frequent scientific exchange, regular visits and projects with joint data analysis.
On behalf of our collaboration and the National Institute of Cardiovascular Outcomes Research (NICOR), UK, John Deanfield and colleagues are in the process of applying for joint funding in the field of personalised prevention of secondary heart diseases.